Silva, Djúlio César Zanin da; Gonçalves, Maynara Santana; Vasconcelos, Marianna Yumi Kawashima; Rodrigues, Maria Carolina de Oliveira 
Source: Frontiers in Medicine. Unidade: FMRP
Subjects: TERAPIA BIOLÓGICA, CÉLULAS ENDOTELIAIS, ESCLEROSE ÓSSEA, VASODILATAÇÃO, CÉLULAS ENDOTELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Djúlio César Zanin da et al. Management of endothelial dysfunction in systemic sclerosis: current and developing strategies. Frontiers in Medicine, v. 8, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmed.2021.788250. Acesso em: 13 fev. 2026.APA
Silva, D. C. Z. da, Gonçalves, M. S., Vasconcelos, M. Y. K., & Rodrigues, M. C. de O. (2021). Management of endothelial dysfunction in systemic sclerosis: current and developing strategies. Frontiers in Medicine, 8, 1-14. doi:10.3389/fmed.2021.788250NLM
Silva DCZ da, Gonçalves MS, Vasconcelos MYK, Rodrigues MC de O. Management of endothelial dysfunction in systemic sclerosis: current and developing strategies [Internet]. Frontiers in Medicine. 2021 ; 8 1-14.[citado 2026 fev. 13 ] Available from: https://doi.org/10.3389/fmed.2021.788250Vancouver
Silva DCZ da, Gonçalves MS, Vasconcelos MYK, Rodrigues MC de O. Management of endothelial dysfunction in systemic sclerosis: current and developing strategies [Internet]. Frontiers in Medicine. 2021 ; 8 1-14.[citado 2026 fev. 13 ] Available from: https://doi.org/10.3389/fmed.2021.788250
